• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

¹¹C-甲基-4'-硫代胸腺嘧啶正电子发射断层扫描/计算机断层扫描与¹⁸F-2-脱氧-D-葡萄糖在晚期头颈部鳞状细胞癌患者中的容积比较

Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.

作者信息

Ito Kimiteru, Yokoyama Junkichi, Miyata Yoko, Toyohara Jun, Okasaki Momoko, Minamimoto Ryogo, Morooka Miyako, Ishiwata Kiichi, Kubota Kazuo

机构信息

aDepartment of Radiology, Division of Nuclear Medicine, National Center for Global Health and Medicine bDepartment of Otolaryngology, Head and Neck Surgery, Juntendo University School of Medicine cResearch Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology dDepartment of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

出版信息

Nucl Med Commun. 2015 Mar;36(3):219-25. doi: 10.1097/MNM.0000000000000241.

DOI:10.1097/MNM.0000000000000241
PMID:25369751
Abstract

OBJECTIVE

We prospectively compared the diagnostic value of PET/computed tomography (CT) findings using the tracers 4'-[methyl-11C]-thiothymidine (11C-4DST) and 2-deoxy-2-18F-fluoro-D-glucose (18F-FDG) in patients with head and neck squamous cell carcinoma (HNSCC).

PATIENTS AND METHODS

Thirty-eight patients with advanced HNSCC underwent 11C-4DST PET/CT and 18F-FDG PET/CT before treatment. Maximum standardized uptake values (SUVmax) were measured for both PET/CT studies; in addition, total lesion glycolysis (TLG) of 18F-FDG PET/CT and total lesion proliferation (TLP) of 11C-4DST PET/CT were measured. Absolute TLG and TLP values as well as values with various SUV thresholds were measured. All patients were followed up for 13.5±7.5 months (mean±SD) to monitor recurrence.

RESULTS

A statistically significant correlation was observed between the primary tumor SUVmax for 11C-4DST PET/CT and 18F-FDG PET/CT (r=0.46, P<0.01). TLP values with SUV thresholds strongly correlated with TLG values relative to the same thresholds (r=0.60-0.92, P<0.001). Nine of the 38 patients with post-treatment recurrence were identified. Receiver operating characteristic curves for TLG3.0 and TLP2.5 showed the highest prognostic ability for recurrence; the sensitivity and specificity of TLG3.0 were 89 and 72%, respectively, and the sensitivity and specificity of TLP2.5 were 89 and 55%, respectively.

CONCLUSION

In patients with advanced HNSCC, the TLP of 11C-4DST PET/CT strongly correlated with the TLG of 18F-FDG PET/CT. Although there were no large differences between these values, the receiver operating characteristic curves of the absolute TLG had slightly better prognostic ability for recurrence.

摘要

目的

我们前瞻性地比较了使用示踪剂4'-[甲基-11C]-硫代胸腺嘧啶核苷(11C-4DST)和2-脱氧-2-18F-氟-D-葡萄糖(18F-FDG)的PET/计算机断层扫描(CT)检查结果对头颈部鳞状细胞癌(HNSCC)患者的诊断价值。

患者与方法

38例晚期HNSCC患者在治疗前接受了11C-4DST PET/CT和18F-FDG PET/CT检查。对两项PET/CT检查均测量了最大标准化摄取值(SUVmax);此外,还测量了18F-FDG PET/CT的总病灶糖酵解(TLG)和11C-4DST PET/CT的总病灶增殖(TLP)。测量了绝对TLG和TLP值以及具有不同SUV阈值的值。所有患者均随访13.5±7.5个月(均值±标准差)以监测复发情况。

结果

观察到11C-4DST PET/CT和18F-FDG PET/CT的原发肿瘤SUVmax之间存在显著的统计学相关性(r = 0.46,P < 0.01)。具有SUV阈值的TLP值与相对于相同阈值的TLG值高度相关(r = 0.60 - 0.92,P < 0.001)。38例治疗后复发的患者中有9例被识别出来。TLG3.0和TLP2.5的受试者工作特征曲线显示出对复发的最高预后能力;TLG3.0的敏感性和特异性分别为89%和72%,TLP2.5的敏感性和特异性分别为89%和55%。

结论

在晚期HNSCC患者中,11C-4DST PET/CT的TLP与18F-FDG PET/CT的TLG高度相关。尽管这些值之间没有很大差异,但绝对TLG的受试者工作特征曲线对复发的预后能力略好。

相似文献

1
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.¹¹C-甲基-4'-硫代胸腺嘧啶正电子发射断层扫描/计算机断层扫描与¹⁸F-2-脱氧-D-葡萄糖在晚期头颈部鳞状细胞癌患者中的容积比较
Nucl Med Commun. 2015 Mar;36(3):219-25. doi: 10.1097/MNM.0000000000000241.
2
Influence of volumetric 4'-[methyl-C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients.体积4'-[甲基-C]-硫代胸苷PET/CT参数对头颈部癌患者临床结局预测的影响
Ann Nucl Med. 2017 Jan;31(1):63-70. doi: 10.1007/s12149-016-1131-6. Epub 2016 Sep 27.
3
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.头颈部鳞状细胞癌放化疗前正电子发射断层扫描/计算机断层扫描上的氟脱氧葡萄糖热点与局部复发优势部位之间的相关性
Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6.
4
4'-[methyl-C]-thiothymidine as a proliferation imaging tracer for detection of colorectal cancer: comparison with F-FDG.4'-[甲基-C]-硫代胸苷作为增殖显像示踪剂检测结直肠癌:与 F-FDG 的比较。
Ann Nucl Med. 2019 Nov;33(11):822-827. doi: 10.1007/s12149-019-01393-2. Epub 2019 Aug 10.
5
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.标准化摄取值和代谢肿瘤体积在¹⁸F-FDG PET/CT上对口咽鳞状细胞癌的预后意义
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61. doi: 10.1007/s00259-015-3051-4. Epub 2015 Jun 12.
6
Interim 4'-[methyl-C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [F]FDG PET.用于预测头颈部鳞状细胞癌放化疗反应的中期4'-[甲基-C]-硫代胸苷PET:与[F]FDG PET的比较
EJNMMI Res. 2021 Feb 10;11(1):13. doi: 10.1186/s13550-021-00749-y.
7
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.氟代脱氧葡萄糖正电子发射断层显像/增强CT作为头颈部鳞状细胞癌的治疗后评估工具:与氟代脱氧葡萄糖正电子发射断层显像/非增强CT及增强CT的比较
Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19.
8
4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer.4'-[甲基-11C]-硫代胸苷 PET/CT 用于非小细胞肺癌的增殖显像。
J Nucl Med. 2012 Feb;53(2):199-206. doi: 10.2967/jnumed.111.095539. Epub 2011 Dec 21.
9
Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.飞行时间技术对¹⁸F-FDG PET/CT评估头颈部鳞状细胞癌淋巴结转移诊断性能的影响。
J Nucl Med Technol. 2014 Sep;42(3):181-7. doi: 10.2967/jnmt.114.141192. Epub 2014 Jun 26.
10
Assessment of biological parameters in head and neck cancer based on in vivo distribution of F-FDG-FLT-FMISO-PET/CT images.基于F-FDG-FLT-FMISO-PET/CT图像的体内分布对头颈部癌生物学参数的评估。
Tumori. 2020 Feb;106(1):33-38. doi: 10.1177/0300891619868012. Epub 2019 Aug 26.

引用本文的文献

1
Proliferation PET/CT Imaging of Salivary Gland Tumor.唾液腺肿瘤的增殖性PET/CT成像
Diagnostics (Basel). 2021 Nov 8;11(11):2065. doi: 10.3390/diagnostics11112065.
2
Interim 4'-[methyl-C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [F]FDG PET.用于预测头颈部鳞状细胞癌放化疗反应的中期4'-[甲基-C]-硫代胸苷PET:与[F]FDG PET的比较
EJNMMI Res. 2021 Feb 10;11(1):13. doi: 10.1186/s13550-021-00749-y.
3
Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors.
11C-4DST PET/CT 临床价值评估肺良恶性肿瘤。
Ann Nucl Med. 2021 Feb;35(2):211-222. doi: 10.1007/s12149-020-01554-8. Epub 2021 Jan 2.
4
Evaluation of DNA synthesis with carbon-11-labeled 4'-thiothymidine.用碳-11标记的4'-硫代胸苷评估DNA合成。
World J Radiol. 2016 Sep 28;8(9):799-808. doi: 10.4329/wjr.v8.i9.799.